This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh. Active years: 2003-2012.
Company Filing History:
5 out of 1,855 
1 out of 330 
Years Active: 2003-2012
Title: Ekkehard Leberer: Innovator in Medical Research
Introduction
Ekkehard Leberer is a notable inventor based in Germering, Germany. He has made significant contributions to the field of medical research, particularly in the development of treatments for joint diseases. With a total of 6 patents to his name, Leberer's work has the potential to impact many lives.
Latest Patents
Leberer's latest patents include innovative approaches to medical treatment. One of his notable inventions is the use of a p21-activated kinase (PAK) inhibitor for the treatment of joint diseases. This invention focuses on utilizing a PAK inhibitor as a target protein for discovering new medicaments. Another significant patent involves a method for screening gamma-secretase activity. This invention relates to an improved process for determining gamma-secretase activity and detecting related proteins. It also includes processes for identifying substances that can inhibit the activity of gamma-secretase.
Career Highlights
Throughout his career, Ekkehard Leberer has worked with prominent companies in the pharmaceutical industry. He has been associated with Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. His experience in these organizations has contributed to his expertise in medical research and innovation.
Collaborations
Leberer has collaborated with several professionals in his field, including Thomas Leeuw and Joerg Czech. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.
Conclusion
Ekkehard Leberer is a distinguished inventor whose work in medical research has led to valuable patents. His contributions to the treatment of joint diseases and the understanding of gamma-secretase activity highlight his innovative spirit and dedication to improving healthcare.